The incidence of adjacent synchronous invasive carcinoma and/or ductal carcinoma in situ in patients with intraductal papilloma without atypia on core biopsy: results …
F Nakhlis, GM Baker, M Pilewskie, R Gelman… - Annals of surgical …, 2021 - Springer
Background Available retrospective data suggest the upgrade rate for intraductal papilloma
(IP) without atypia on core biopsy (CB) ranges from 0 to 12%, leading to variation in …
(IP) without atypia on core biopsy (CB) ranges from 0 to 12%, leading to variation in …
Outcomes of benign intraductal papillomas diagnosed on core biopsy: a review of 104 cases with subsequent excision from a single institution
JR Asirvatham, JM Jorns, L Zhao, DO Jeffries, AJ Wu - Virchows Archiv, 2018 - Springer
A diagnosis of papilloma with atypia on core biopsy (CB) requires excision, as the risk of
associated malignancy is high (average 36.9%). The management of benign intraductal …
associated malignancy is high (average 36.9%). The management of benign intraductal …
Papilloma diagnosed on core biopsies has a low upgrade rate
X Li, M Aho, MS Newell, K Clifford, JG Patel, S Jou… - Clinical Imaging, 2020 - Elsevier
Context Surgical excision of benign intraductal papillomas (IDP) diagnosed on core needle
biopsy (CNB) remains controversial. Objective To examine the upgrade rate of IDPs …
biopsy (CNB) remains controversial. Objective To examine the upgrade rate of IDPs …
Are we overtreating intraductal papillomas?
S Kiran, YJ Jeong, ME Nelson, A Ring… - Journal of Surgical …, 2018 - Elsevier
Background The management of intraductal papillomas (IDPs) diagnosed on core needle
biopsy (CNB) remains controversial regarding whether excision is required. We evaluated …
biopsy (CNB) remains controversial regarding whether excision is required. We evaluated …
Upgrade rates of intraductal papilloma with and without atypia diagnosed on core needle biopsy and clinicopathologic predictors
H Corbin, P Bomeisl, AL Amin, HN Marshall, H Gilmore… - Human Pathology, 2022 - Elsevier
Surgical excision of breast intraductal papilloma (IDP) without atypia diagnosed on core
needle biopsy (CNB) is controversial as the risk of upgrade to malignant lesions is not well …
needle biopsy (CNB) is controversial as the risk of upgrade to malignant lesions is not well …
Upgrade rate of intraductal papilloma without atypia on breast core needle biopsy: a clinical, radiological and pathological correlation study
IS Genco, B Tugertimur, PA Manolas… - The American Journal of …, 2020 - Elsevier
Background The aim of the study was to determine the upgrade rate on excision of
intraductal papilloma (IDP) without atypia diagnosed on breast core needle biopsy (CNB) …
intraductal papilloma (IDP) without atypia diagnosed on breast core needle biopsy (CNB) …
Upgrade rate and predictive factors for breast benign intraductal papilloma diagnosed at biopsy: a meta-analysis
X Zhang, W Liu, T Hai, F Li - Annals of Surgical Oncology, 2021 - Springer
Background Current standard management for intraductal papilloma (IDP) diagnosed at
biopsy indicates complete surgical resection, but there are increasing controversies over …
biopsy indicates complete surgical resection, but there are increasing controversies over …
Intraductal papillomas on core biopsy can be upgraded to malignancy on subsequent excisional biopsy regardless of the presence of atypical features
S Shiino, H Tsuda, M Yoshida, K Jimbo… - Pathology …, 2015 - Wiley Online Library
Intraductal papillary lesions of the breast constitute a heterogeneous entity, including benign
intraductal papilloma (IDP) with or without atypia and malignant papillary carcinoma …
intraductal papilloma (IDP) with or without atypia and malignant papillary carcinoma …
[PDF][PDF] Benign intraductal papilloma without atypia on core needle biopsy has a low rate of upgrading to malignancy after excision
SH Han, M Kim, YR Chung, B La Yun… - Journal of breast …, 2018 - synapse.koreamed.org
Purpose: The management of benign intraductal papilloma (IDP) without atypia diagnosed
on core needle biopsy (CNB) remains controversial. This study was performed to evaluate …
on core needle biopsy (CNB) remains controversial. This study was performed to evaluate …
Should we excise? Are there any clinical or histologic features that predict upgrade in papillomas, incidental or non-incidental?
M Zaleski, YA Chen, AL Chetlen, J Mack, L Xu… - Annals of Diagnostic …, 2018 - Elsevier
The clinical decision to excise intraductal papilloma (IDP) without atypia diagnosed on
biopsy remains controversial. We sought to establish clinical and histologic predictors (if …
biopsy remains controversial. We sought to establish clinical and histologic predictors (if …